PUBLISHER: GlobalData | PRODUCT CODE: 2182625
PUBLISHER: GlobalData | PRODUCT CODE: 2182625
Colorectal cancer (International Classification of Diseases, 10th Revision [ICD-10] code = C18-C20), also referred to as bowel cancer, is the cancer of the colon, rectum, or rectosigmoid junction. It is a type of gastrointestinal malignancy that originates from either the colon or the rectum. Although both forms can be defined as colon or rectal cancers, depending on their origin, they are often merged because of their many biologically and clinically common features (American Cancer Society, 2024b, 2024c, 2025). In 2024, lung cancer was the most frequently diagnosed malignancy globally with 2.6 million new cases, followed closely by breast cancer (2.4 million cases) and colorectal cancer (2.0 million cases). Ranking as the third most prevalent cancer globally, colorectal cancer is also highly fatal, trailing only lung cancer with 918,000 recorded deaths that same year (World Health Organization, 2026).
The report also provides a 10-year epidemiological forecast of the five-year diagnosed prevalent cases of colorectal cancer. This epidemiology forecast for colorectal cancer is supported by data obtained from national and country-specific cancer registries and population-based studies published in peer-reviewed journals. The forecast methodology was kept consistent across the 8MM to allow for a meaningful comparison of the forecast diagnosed incident and diagnosed prevalent cases of colorectal cancer across these markets.
In the 8MM, the diagnosed incident cases of colorectal cancer are expected to increase from 914,439 cases in 2025 to 1,121,336 cases in 2035, at an annual growth rate (AGR) of 2.26%. In 2035, urban China will have the highest number of diagnosed incident cases of colorectal cancer in the 8MM, with 475,817 cases, whereas France will have the fewest diagnosed incident cases of colorectal cancer, with 56,309 cases.
In the 8MM, the five-year diagnosed prevalent cases of colorectal cancer are expected to increase from 2,984,220 cases in 2025 to 3,643,843 cases in 2035, at an AGR of 2.21%. GlobalData epidemiologists attribute the increase in the five-year diagnosed prevalent cases and diagnosed incident cases of colorectal cancer to changes in the diagnosed incidence and survival rates, as well as population dynamics in each market.